NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Independent reports  «  1  2  3    
found files: 47
»26/02/2010 [Independent reports]
Protecting and Policing IPRs in China

China has emerged as an important economy that enhances registration and enforcement of intellectual property rights (IPRs). China is renowned as the world’s factory, with the emergence of an affluent and growing middle-class....   more»

Sundia MediTech Company,Ltd. »11/03/2010 [Independent reports]
Lady behind Sundia success: Dr Xiaochuan Wang, China

Sundia, a Shanghai-based integrated pharmaceutical contract research organization is the brainchild of a highly motivated Chinese researcher, Dr Xiaochuan Wang, who worked in the US for over 14 years in three biotech companies after her PhD in molecular structure design of new drugs, from the University of Chicago....   more»

»29/03/2010 [Independent reports]
Asias spectacular rise create serious challenges

Asia spectacular rise—and bright prospects for growth—have created some serious challenges for governments in the region, not least of which are the needs to adapt to changing disease profiles and rapidly ageing populations,” said Mr Charles Goddard, Editorial Director, Asia-Pacific, Economist Intelligence Unit....   more»

»12/04/2010 [Independent reports]
Forecast 2015: The Next BIG trends

The pharmaceutical industry in the last few years has adapted various strategies like shifting R&D focus, reorganizing business units, outsourcing manufacturing and R&D, and retrenchment of employees to improve productivity....   more»

»19/04/2010 [Independent reports]
Special Report: Chuang Yang Huang: Asian expenditure on healthcare to rise

Dr Chung Yang Huang President, Nature Wise Biotech & Medicals Corporation, Taiwan Singapore, Apr 19, 2010: The major trends in life sciences industry include rapid growth of per capita health expenditure in Asia Pacific countries especially in China and India increasing the demand prospect of the industry...   more»

»30/04/2010 [Independent reports]
Pharma Prospects: A billion reasons to invest in China

China is the most populous country on earth with 1.3 billion inhabitants. These people are the reason why China is fast becoming a super power. This is a problem of plenty, as the government needs to provide healthcare to all and providing these many people with adequate healthcare is a task in itself. Here are the factors that beckon pharma companies to China....   more»

»21/05/2010 [Independent reports]
Progress in China medical reform over the past year

The Chinese government unveiled a three-year plan for health care reform, involving an investment of at least 850 billion yuan, in April 2009. During the past year, the reform has brought significant changes to public health care services....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.